Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common stock
-
Shares outstanding
-
47,144,064
-
Total 13F shares
-
12,184,052
-
Share change
-
+1,087,157
-
Total reported value
-
$294,238,682
-
Price per share
-
$24.15
-
Number of holders
-
44
-
Value change
-
+$23,944,526
-
Number of buys
-
28
-
Number of sells
-
10
Institutional Holders of Whitehawk Therapeutics, Inc. - Common stock (WHWK) as of Q4 2021
As of 31 Dec 2021,
Whitehawk Therapeutics, Inc. - Common stock (WHWK) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,184,052 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, ACUTA CAPITAL PARTNERS, LLC, VR Adviser, LLC, Vivo Capital, LLC, BVF INC/IL, RTW INVESTMENTS, LP, VANGUARD GROUP INC, Rock Springs Capital Management LP, PRICE T ROWE ASSOCIATES INC /MD/, and SATTER MANAGEMENT CO., L.P..
This page lists
44
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.